Healing After Myocardial Infarction: A Loosely Defined Process.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. NEAT1 Coordinates a PDLIM5-CACNA1C Regulatory Program Associated with a Potentially Arrhythmogenic Cardiomyocyte State in the Border Zone During Early Myocardial Infarction.International journal of molecular sciences · 2026
   Article
2. Plasma Dilution After Myocardial Ischemia-Reperfusion Injury Promotes Cardiac Repair, Heart Performance, and Recovery of Motor Function and Endurance in Old Mice.Aging cell · 2026
   Article
3. Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction-Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study.Journal of clinical medicine · 2022
   Article
4. The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials.Arrhythmia & electrophysiology review · 2021
   Review
5. Nanomaterials for Cardiac Tissue Engineering.Molecules (Basel, Switzerland) · 2020
   Review
6. Vascular toxic effects of cancer therapies.Nature reviews. Cardiology · 2020
   Review
7. Supplementation with psyllium seed husk reduces myocardial damage in a rat model of ischemia/reperfusion.Nutrition research and practice · 2019
   Article
8. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.Journal of the American Society of Hypertension : JASH · 2018
   Review
9. Cardiotoxicity with vascular endothelial growth factor inhibitor therapy.NPJ precision oncology · 2018
   Review
10. Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage.Circulation · 2017
    Article
11. Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells.Expert opinion on biological therapy
    Review

Corrections and comments

• Comment on
  Performance of CMR Methods for Differentiating Acute From Chronic MI.2015

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as